fashion -WSS

fashion

author：hotspot 2025-08-28 06:18:36 - browse：453

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by a pressing question in medicine: How should new obesity medications be incorporated into regular practice?

Trials have demonstrated that the powerful drugs can help people shed weight in dramatic ways, but clinicians are still trying to sort out how to best use them. The medicines, after all, are pricey, come with side effects, and won’t work for everyone. And despite the excitement around these drugs, known as GLP-1s, some people might prefer or see better results with the other approaches that have long been the foundation of obesity treatment, from diet to surgery.

“These drugs clearly are very effective, and that is fantastic,” said Susan Jebb, a professor of diet and population health at the University of Oxford and one of the leaders of the project. “But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

hotspot

WSS

Caribou posts encouraging results on off

Hormonal contraceptives don’t actually treat endometriosis

Mystery swirls around US soldier who entered North Korea days ago, officials say

How a Boston hospital is priming medical residents to use GPT

Data integrity in scientific journals requires "effort" by publishers, institutions

Cytokinetics CEO stresses company can launch heart drug on its own

explore

fashion

entertainment

Continuity nursing helped my family in our darkest PICU moments

When a patient nears the end, a feared therapy can comfort

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

NVIDIA and Google execs on the future of AI and drug discovery

After affirmative action ruling, medical educators look to 'holistic review'

Mystery swirls around US soldier who entered North Korea days ago, officials say

Alkermes shareholders re

Caribou posts encouraging results on off

Supreme Court strikes down use of affirmative action

Criminal prosecution for violating HIPAA: an emerging threat

focus

Arc Institute generative AI designs new CRISPR systems

Stanford president’s abrupt resignation sparks debate

In rare move, senator releases unverified FBI source report alleging Biden bribe

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Readout LOUD podcast: Live from STAT Breakthrough Summit West

knowledge

focus

hotspot

knowledge